Literature DB >> 23105431

Studies of biochemical parameters in breast cancer with and without metastasis.

Sandhya Mishra1, D C Sharma, Praveen Sharma.   

Abstract

The study includes 102 confirmed cases of carcinoma breast with and without metastasis and 25 healthy non-pregnant females. They were evaluated for blood levels of Ferritin, GSH, LDH, ALP, GGT and Hb before and 21 days after mastectomy. A significant increase (p<0.001) was observed in ferritin, LDH and GSH levels in cancer patients without metastasis in comparison to normal control subjects. Patients with metastasis had further elevated (p<0.001) levels of Ferritin, ALP and GGT as compared to non-metastatic patients. Mastectomy in both the cases i.e. with and without metastasis resulted in non-significant decrease in all the biochemical parameters suggesting that longer follow up could confirm post surgery decrease in the biochemical parameters. The results of the study suggest cost effective, usefulness of Ferritin, ALP, GGT and GSH/Hb ratio in differentiating breast cancer patients with and without metastasis which can be assayed in smaller laboratories.

Entities:  

Keywords:  Alkaline phosphatase; Carcinoma breast; Diagnostic tools; Ferritin; Gamma glutamyl transpeptidase; Glutathione; Lactate dehydrogenase; Metastasis

Year:  2004        PMID: 23105431      PMCID: PMC3453907          DOI: 10.1007/BF02872394

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  19 in total

1.  The glutathione-related detoxification system is increased in human breast cancer in correlation with clinical and histopathological features.

Authors:  M Perquin; T Oster; A Maul; N Froment; M Untereiner; D Bagrel
Journal:  J Cancer Res Clin Oncol       Date:  2001       Impact factor: 4.553

2.  Glutathione and its metabolizing enzymes in patients with different benign and malignant diseases.

Authors:  A H Abou Ghalia; I M Fouad
Journal:  Clin Biochem       Date:  2000-11       Impact factor: 3.281

Review 3.  Serum ferritin.

Authors:  M Worwood
Journal:  Clin Sci (Lond)       Date:  1986-03       Impact factor: 6.124

4.  Serum tumor markers for detection of bone metastasis in breast cancer patients.

Authors:  A Aydiner; E Topuz; R Dişçi; V Yasasever; M Dinçer; K Dinçol; N Bilge
Journal:  Acta Oncol       Date:  1994       Impact factor: 4.089

5.  Elevation of glutathione, glutathione-reductase and nucleic acids in both normal tissues and tumour of breast cancer patients.

Authors:  M M el-Sharabasy; I el-Dosoky; H Horria; A H Khalaf
Journal:  Cancer Lett       Date:  1993-08-16       Impact factor: 8.679

6.  Antioxidant profile in the circulation of patients with fibroadenoma and adenocarcinoma of the breast.

Authors:  R Kumaraguruparan; R Subapriya; J Kabalimoorthy; S Nagini
Journal:  Clin Biochem       Date:  2002-06       Impact factor: 3.281

7.  Alkaline phosphatase isoenzyme patterns in malignant disease.

Authors:  V O Van Hoof; A T Van Oosterom; L G Lepoutre; M E De Broe
Journal:  Clin Chem       Date:  1992-12       Impact factor: 8.327

8.  Serum levels of bone alkaline phosphatase in breast and prostate cancers with bone metastasis.

Authors:  G Ramaswamy; V R Rao; L Krishnamoorthy; G Ramesh; R Gomathy; D Renukadevi
Journal:  Indian J Clin Biochem       Date:  2000-07

9.  Breast and prostate cancer.

Authors:  B K Sharma; A Ray
Journal:  Indian J Clin Biochem       Date:  2000-08

10.  Significance of bone alkaline phosphatase, CA 15-3 and CEA in the detection of bone metastases during the follow-up of patients suffering from breast carcinoma.

Authors:  P Stieber; D Nagel; C Ritzke; N Rössler; C M Kirsch; W Eiermann; A Fateh-Moghadam
Journal:  Eur J Clin Chem Clin Biochem       Date:  1992-12
View more
  8 in total

1.  Local Interleukin-2 Immunotherapy of Breast Cancer: Benefit and Risk in a Spontaneous Mouse Model.

Authors:  Svetlana G Semushina; Dmitry A Aronov; Ekaterina V Moiseeva
Journal:  Pathol Oncol Res       Date:  2018-03-06       Impact factor: 3.201

2.  Oxidative stress and its relationship with adenosine deaminase activity in various stages of breast cancer.

Authors:  Mridula Mahajan; Nitika Tiwari; Ritu Sharma; Sukhraj Kaur; Neetirajan Singh
Journal:  Indian J Clin Biochem       Date:  2012-08-17

3.  Three gold indicators for breast cancer prognosis: a case-control study with ROC analysis for novel ratios related to CBC with (ALP and LDH).

Authors:  Noha Mohamed Said
Journal:  Mol Biol Rep       Date:  2019-01-31       Impact factor: 2.316

4.  Preliminary Study on Serum Lactate Dehydrogenase (LDH)-Prognostic Biomarker in Carcinoma Breast.

Authors:  Aditi Agrawal; Mahendra Bhauraoji Gandhe; Dilip Gupta; M V R Reddy
Journal:  J Clin Diagn Res       Date:  2016-03-01

5.  Correlation Between Gamma-Glutamyl Transferase Activity and Glutathione Levels in Molecular Subgroups of Breast Cancer.

Authors:  Sevgi Yardım Akaydın; Ece Miser Salihoğlu; Dilek Gelen Güngör; Hasan Karanlık; Semra Demokan
Journal:  Eur J Breast Health       Date:  2019-12-05

6.  Advanced stage of breast cancer hoist alkaline phosphatase activity: risk factor for females in India.

Authors:  A K Singh; A Pandey; M Tewari; R Kumar; A Sharma; K A Singh; H P Pandey; H S Shukla
Journal:  3 Biotech       Date:  2013-01-06       Impact factor: 2.406

7.  Pre-treatment serum alkaline phosphatase and lactate dehydrogenase as prognostic factors in triple negative breast cancer.

Authors:  Bo Chen; Danian Dai; Hailin Tang; Xi Chen; Xiaohong Ai; Xiaojia Huang; Weidong Wei; Xiaoming Xie
Journal:  J Cancer       Date:  2016-11-25       Impact factor: 4.207

8.  Amelioration of carcinogen-induced toxicity in mice by administration of a potentized homeopathic drug, natrum sulphuricum 200.

Authors:  Nandini Bhattacharjee; Surajit Pathak; Anisur Rahman Khuda-Bukhsh
Journal:  Evid Based Complement Alternat Med       Date:  2007-06-19       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.